Position in RVMD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$142,975,918
+$60,837,210 QoQ
Shares Held
763,434
-9.6% QoQ
Ownership
0.356%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 83%
Shared 12%
None 5%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,748,551 across 230 Biotechnology names. RVMD ranks #12 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in RVMD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $142,975,918 | 763,434 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $82,138,708 | 844,614 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $92,525,102 | 1,161,646 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $67,286,197 | 1,440,818 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $36,647,399 | 996,124 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,215,941 | 373,754 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $16,961,278 | 387,775 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,889,350 | 394,473 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $15,158,526 | 390,583 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $42,906,476 | 1,331,259 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $51,492,672 | 1,795,421 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $46,000,366 | 1,661,863 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $44,639,757 | 1,668,776 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $34,872,315 | 1,609,987 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $27,390,448 | 1,149,893 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $18,468,094 | 936,516 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,292,282 | 630,697 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $12,213,575 | 478,776 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,539,157 | 180,340 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $753,774 | 27,400 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||